SIR 2026

Intra-Arterial (IA) Padeliporfin Vascular-Targeted Photodynamic Therapy (VTP): Ongoing Multicenter, Phase I Light Dose Escalation Study in Unresectable Locally Advanced Pancreatic Ductal Adenocarcinoma (LA-PDAC)

Presenting Author(s)

• 

  Nadine Abi-Jaoudeh, MD, FSIR (she/her/hers)

  Professor of Radiology
  University of California, United States

Author/Co-author(s)

• JV

  Jennifer Valerin, MD, PhD

  Assistant Clinical Professor
  Division of Hematology/Oncology, Department of Medicine, University of California Irvine, United States
• DP

  Dina Preise, PhD

  Head clinical and non clinical sciences
  Impact Biotech, Israel
• GA

  Genia Alpert, MD, PhD

  Medical Director
  Impact Biotech, Israel
• KB

  Keren Brook, MS

  Clinical project lead
  Impact Biotech, Israel
• NW

  Nick Weinberger, MS

  Medical Science Liason
  Impact Biotech, Israel
• DP

  David Perry, MD

  Medical monitor
  Impact Biotech, Israel
• AC

  April Choi, MD

  Oncologist
  University of California Irvine, Irvine, CA, United States
• AS

  Avigdor Scherz, PhD

  Professor (EProfessor of meritus), Faculty of Biochemistry
  Weizmann Institute of Science, Israel
• EM

  Eyal Morag, MD

  CMO
  Impact Biotech, Israel
• VC

  Vincent Chung, MD

  Oncology
  City of Hope, United States
• LM

  Laleh Melstrom, MD

  Oncology
  City of Hope, United States
• JK

  Jonathan Kessler, MD

  Interventional Radiology Attending
  City of Hope Medical Center, United States
• DI

  David K. Imagawa, MD, PhD

  Chief of Hepatobiliary and Pancreas Surgery/Islet Cell Transplantation
  Division of Hepatobiliary and Pancreas Surgery, Surgery, United States